The U.S. will impose tariffs of as much as 100% on branded pharmaceuticals, the White House said Thursday, though nations or drugmakers that strike deals with the Trump administration or commit to build manufacturing facilities in the U.S. can receive lower levies. The 100% tariff will apply to patented imported pharmaceuticals from companies that haven’t committed to invest in the U.S. and haven’t entered into “most favored nation” agreements to match their U.S. prices to the lowest they charge in other developed countries, a senior administration official said Thursday. But the full 100% tariff might apply to only a few…

Want to continue reading?

Unlock full access to The Currency and The Wall Street Journal with an Annual membership and receive a free Samsonite suitcase – worth €235 delivered to your door.

Subscribe

Cancel at any time.

Are you already a member? .